MRKR Next Earnings Date Notes

— Marker Therapeutics (MRKR) is a clinical-stage immuno-oncology company developing novel T cell-based therapies for cancer. Unlike traditional CAR-T or TCR approaches, Marker's MultiTAA-specific T cell therapy harnesses the patient’s own immune system to target multiple tumor-associated antigens (TAAs) simultaneously, aiming to improve efficacy & reduce the risk of relapse or treatment resistance. The company's most advanced programs focus on blood cancers such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and lymphoma, with ongoing clinical trials evaluating both safety & efficacy. For investors listening to MRKR's earnings calls, important metrics to track include clinical trial progress (particularly patient recruitment, data readouts, & regulatory milestones), cash runway & operating expenses (as a pre-revenue biotech, Marker's financial longevity depends on prudent cash management), as well as any partnerships or licensing agreements that could signal commercial opportunities or de-risk the pipeline. Long-term performance will be most influenced by the clinical data resulting from their lead programs and the company's ability to advance toward late-stage trials or eventual FDA approval. The next projected earnings date for MRKR is 8/13/2026 5:00 pm (stay tuned for a confirmed earnings date once announced).

MRKR Next Earnings Date FAQ

On this page we presented the MRKR Next Earnings Date information for Marker Therapeutics along with recent past earnings dates. For Q1 of 2026, MRKR reported earnings of -0.160/share, with the earnings report taking place on 5/15/2026. For Q4 of 2025, MRKR reported earnings of -0.087/share, with the earnings report taking place on 3/18/2026. For Q3 of 2025, MRKR reported earnings of -0.120/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, MRKR reported earnings of -0.290/share, with the earnings report taking place on 8/14/2025. For Q1 of 2025, MRKR reported earnings of -0.400/share, with the earnings report taking place on 5/15/2025. Based on these past earnings dates, the projected next earnings date for MRKR is 8/13/2026 5:00 pm.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Marker Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Marker Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Marker Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next MRKR earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MRKR's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MRKR next earnings date.